Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £20.17m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

UK neonatal division wins NHS framework agreement

5 Mar 2026 07:00

RNS Number : 3861V
Inspiration Healthcare Group PLC
05 March 2026
Β 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Β 

UK neonatal division secures renewed four-year NHS framework agreement

No. 1 position in neonatal ventilator suppliers to England & Wales NHS

Β 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces that it has been re-appointed by the NHS supply chain as an approved supplier for its respiratory care units for newborns under a new four-year framework agreement covering England and Wales. In addition, the Company has been ranked as the number one neonatal ventilator supplier* for the 2025/26 period under the NHS framework in England and Wales.

Β 

Strategic and financial impact

Β 

Β· Secures framework position for four years, providing enhanced medium-term revenue visibility within the UK market

Β· Reinforces Inspiration Healthcare's market-leading position in neonatal ventilation across England and Wales

Β· Supports ongoing capital equipment sales, associated consumables and service revenue streams

Β· Strengthens competitive positioning in future procurement cycle

Β 

The renewed framework appointment ensures continued streamlined access for NHS Trusts to Inspiration Healthcare's portfolio of neonatal respiratory and critical care solutions for vulnerable patients. Framework inclusion supports procurement efficiency, regulatory compliance and value-based purchasing across the healthcare system, enabling NHS Trusts to obtain equipment through a compliant and pre-approved route. The four-year term provides enhanced visibility of opportunity within the NHS procurement cycle and strengthens the Company's strategic positioning in the UK neonatal care market.

Β 

Raffi Stepanian, CEO of Inspiration Healthcare, said: "The renewal of this framework and our ranking within the NHS reflects our continued commitment to medical excellence, innovation and the advancement of clinical outcomes within neonatal intensive care environments. Our neonatal ventilator systems are designed to deliver precise, reliable respiratory support for premature and critically ill newborns, and we are consistently investing in product development, clinical training and service support to ensure that clinicians are equipped to support safe and effective care for vulnerable patients. We remain focused on converting this strategic positioning into further market share gains and long-term shareholder value."

Β 

\* The number one ranking reflects the Company's leading market share position within the NHS supply chain neonatal ventilator category for the designated period.

Β 

For further information, please contact:

Β 

Inspiration Healthcare Group plc

Tel: +44 (0)330 175 0000

Raffi Stepanian, Chief Executive Officer

Alan Olby, Chief Financial Officer

Panmure Liberum (Nominated Adviser & Broker)

Tel: +44 (0)20 3100 2000

Will Goode

Emma Earl

Mark Rogers

Β 

Cavendish Capital Markets (Joint Broker)

Tel: + 44 (0)20 7220 0500

Giles Balleny / Joe Smith

Nigel Birks

Harriet Ward

Β 

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com

Anna Dunphy

Mob: +44 (0) 7876 741 001

Rachel Broad

Mob: +44 (0) 7747 515 393

Β 

About Inspiration Healthcare

Β 

Inspiration Healthcare (AIM: IHC)Β designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

Β 

The Company has a broad portfolio of its own products andΒ complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

Β 

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

Β 

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Β 

Further information on Inspiration Healthcare can be found atΒ www.inspirationhealthcaregroup.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGRUPUWCWUPQGMC
Date   Source Headline
16th Jun 20267:00 amRNSFinal Results
2nd Jun 20267:01 amRNSNotice of Results
2nd Jun 20267:00 amRNSTransfer of Non-Core Products to Focus on Neonatal
14th Apr 20267:00 amRNSChange of Adviser
16th Mar 20269:33 amRNSHolding(s) in Company
16th Mar 20269:33 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSUK neonatal division wins NHS framework agreement
26th Feb 20269:23 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSFull year trading update
10th Feb 20269:05 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSAppointment of Joint Broker
2nd Feb 202611:01 amRNSHolding(s) in Company
28th Jan 20261:40 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSPurchasing agreement in the US
27th Jan 20269:46 amRNSHolding(s) in Company
26th Jan 202610:02 amRNSHolding(s) in Company
22nd Jan 20261:37 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSChange of auditor
16th Oct 20251:51 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHalf-year Report
23rd Sep 20257:00 amRNSResults presentations for analysts and investors
19th Sep 20257:00 amRNSDirectorate Change
20th Aug 20257:00 amRNSTrading update and notice of results
24th Jul 20251:37 pmRNSResult of AGM
24th Jul 20257:00 amRNSAGM Statement
13th Jun 20259:16 amRNSPublication of AR, accounts & notice of AGM
6th Jun 20257:00 amRNSBoard Change
28th May 20257:00 amRNSUnaudited Preliminary results
23rd May 20257:00 amRNSNotice of Results
15th May 20255:01 pmRNSHolding(s) in Company
15th May 202510:06 amRNSHolding(s) in Company
1st Apr 202511:36 amRNSHolding(s) in Company
21st Mar 20252:49 pmRNSGrant of Options
12th Mar 20256:01 pmRNSHolding(s) in Company
12th Mar 20256:00 pmRNSDirector/PDMR Shareholding
24th Feb 20254:16 pmRNSDirector/PDMR Shareholding
21st Feb 20252:52 pmRNSDirector/PDMR Shareholding
18th Feb 20257:00 amRNSTrading update
10th Feb 20259:54 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirectorate Change
14th Jan 20254:08 pmRNSHolding(s) in Company
12th Dec 20247:00 amRNSAppointment of Chief Executive Officer
14th Nov 20247:00 amRNSBoard Change
4th Nov 20247:00 amRNSGrant of Covenant Waiver and Covenant Reset
2nd Oct 20247:00 amRNSHalf-year Report
17th Sep 202412:26 pmRNSResult of AGM
3rd Sep 20247:00 amRNSTrading update for the six months to 31 July 2024
5th Aug 20243:41 pmRNSHolding(s) in Company
2nd Aug 20247:00 amRNSNominated adviser and broker
31st Jul 20243:29 pmRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.